Click To Download

Persons Reported to be living with HIV infection and with AIDS reported

Year Adults/Adolescents Children Under 13 Years old Total Cumulative Totals
  HIV AIDS HIV AIDS HIV AIDS Adults / Adolescents Children Under 13 Years old Total
2000 7,611 5,774 61 69 7,672 5,843 13,385 130 13,515
2001

7,990

6,373

53 70 8,043 6,443 14,363 123 14,486
2002 9,198 7,382 79 61 9,277 7,443 16,580 140 16,720
                   

 

HIV Infection Cases  from areas with confidential HIV infection reporting

Year   Cumulative Totals
    Adults / Adolescents Children Under 13 Years old Total
2000 769 8,160 78 8,238
2001 879 8,609 75 8,684
2002 999 9,198 79 9,277
         

 

Adult/Adolescent HIV infection and AIDS cases reported in the United States

Year Males Females
  HIV AIDS HIV AIDS
2000 524 665 240 219
2001 607 701 269 243
         

 

New Pediatric AIDS cases reported

Year
2000 7
2001 7

 

AIDS cases and annual rates per 100,000 population by Metropolitan area reported through June 2001

 

 1999

2000

2001

Cumulative Totals

City No No. No. Adults / Adolescents Children under 13 Years old Total

Norfolk

272 271 334 4,061 63 4.124
Richmond 183 168 126 2,716 29 2,745

 


Cumulative AIDS Cases

Cumulative Number of AIDS Cases, Reported through 2002 14,959
Cumulative Number of Adult/Adolescent AIDS Cases, Reported through 2002 14,780
Cumulative Number of AIDS Cases in Children <13, Reported through 2002 179

Distribution of Cumulative Adult/Adolescent AIDS Cases by Gender, Reported through June 2002

  VA USA
Men 11,835 680,909
Women 2,482 146,298
Total 14,317 827,208

 

New AIDS Cases

New AIDS Cases, Reported through 2002 955
New Adult/Adolescent AIDS Cases, Reported in 2001 944
New AIDS Cases in Children <13, Reported through December 2001 7

Distribution of New Adult/Adolescent AIDS Cases by Gender, Reported in 2001

  VA USA
Men 701 31,901
Women 243 11,082
Total 944 42,983

 

Persons Living with AIDS

Estimated Number of Persons Living with AIDS at the End of 2002 7,443
Estimated Number of Adults/Adolescents Living with AIDS at the End of 2002 7,382
Estimated Number of Children Living with AIDS at the End of 2002 61
HIV Infection Cases Reported in 2002 999

 

Total Deaths Reported through 2000, due to AIDS = 7,313
HIV Reporting Requirements ?   Yes, Name Based.
 
HIV Testing Options?  Confidential testing only.
Definitions:
Anonymous test: Individual does NOT use their name, and a name is not associated with test result. Anonymous tests are offered at anonymous testing centers, available in many, but not all, states.
Confidential test: Individual DOES use their name. If test is positive, individual's name will be known to their health care provider and, potentially, to other health care professionals and, in some cases, your state's Department of Health.
 
HIV Testing for Mothers and Newborns
Voluntary or Mandatory Testing?
 
Providers required to offer HIV test. Providers are required by law to offer HIV testing to pregnant women.
Voluntary HIV Testing: All states and the District of Columbia have certified to the CDC that they have measures in place to implement the CDC's 1995 recommendations on HIV counseling and testing of pregnant women.  The CDC's 1995 recommendations state that HIV testing of pregnant women and infants should be voluntary and providers must obtain informed consent for testing as required by their state laws.  Voluntary testing is noted if the state follows the CDC guidelines but does not have specific guidelines for testing of mothers and newborns.
 
Status of State Medicaid Expansion Efforts for People with HIV
Approved 1115 Waiver, TWWIIA demonstration?
NO

Definitions:
1115 Waivers: Section 1115 of the Social Security Act authorizes the executive branch of the Federal government to waive the statutory and regulatory provisions of the Medicaid program. States have used "1115 waivers" to make changes in eligibility, benefits, and other areas of their Medicaid programs. The Centers for Medicare and Medicaid Services (CMS--formerly known as the Health Care Financing Administration) and several states have been analyzing the implications of expanding Medicaid eligibility to people with HIV prior to disability through the use of Section 1115 waivers of the Social Security Act. To use 1115 waivers, states face several challenges, particularly the need to demonstrate "budget neutrality" to the Medicaid program - that the costs of an expansion over a designated period of time (usually 5 years) would not exceed the costs to Medicaid in the absence of the expansion.
Ticket to Work/Work Incentives Improvement Act of 1999: TWWIIA expanded State options under Medicaid by creating new Medicaid buy-in options for working individuals with disabilities and extended Medicare cover-age for working individuals with disabilities. The Act also authorized state demonstration programs to provide Medicaid to workers with potentially severe disabilities, including HIV/AIDS, who are not yet disabled but whose health conditions could be expected to cause disability.
Notes: Most people with HIV who qualify for Medicaid do so by meeting the program’s income and disability standards once their illness has already progressed. Many low income people with HIV may be faced with of having their eligibility postponed until they become disabled, even though there are therapies available that may prevent disability and national treatment guidelines recommend access to early treatment. 1115 Waivers and TWWIIA demonstrations are two ways in which states have sought to address this limitation.

 

Sterile Syringe Exchange Programs?  No
Notes:
U.S. totals include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and independent nations in free association with the United States.
Definitions: Programs in operation: includes both state-sanctioned syringe exchange programs and non-sanctioned programs. Because their operation may not necessarily be authorized, it is difficult to account for an exact number of syringe exchange programs operation across the country; therefore, the list may not be comprehensive.
 
STD/HIV/AIDS Education Requirement?  No, If taught voluntarily, must cover abstinence and contraception.
 
Minors' Right to Consent to HIV/STD Services?  Yes. State explicitly classifies HIV/AIDS as an STD or infectious disease, for which minors may consent to testing and treatment.
 

 

Total Ryan White Funding, FY2000   $21,605,804 FY2002  $29,347,675

 

CDC HIV Prevention Funding for States
 FY2001 
$5,100,755

FY2003   $5,156,853
 

 

Total Federal and State Funding for ADAP, FY2001  $17,262,164

Definitions: ADAPs: AIDS Drug Assistance Programs (ADAPs), authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV-related prescription drugs to underinsured and uninsured individuals living with HIV/AIDS. Each state or territory administers its own ADAP.

 

AIDS Drug Assistance Programs (ADAPs)
Source Kaiser Family Foundation

Total ADAP Clients Served, June 2002  
  VA
#
US
#
   1,480 80,035

 
ADAP Clients Served by Sex, June 2002  
  VA
#
VA
%
US
#
US
%
  Male 1,036 70 62,034 78
  Female 444 30 16,702 21
  Total 1,480 100 79,531 100

 
ADAP Clients Served by Race/Ethnicity, June 2002  
  VA
#
VA
%
US
#
US
%
  White 457 31 29,426 37
  Black 716 48 26,245 33
  Hispanic 73 5 19,883 25
  Asian/Pacific Islander 21 1 795 1
  American Indian/Alaskan Native 3 0 795 1
  Other 210 14 795 1
  Total 1,480 100 79,531 100

 
ADAP Clients Served by Age, June 2002
  VA
#
VA
%
US
#
US
%
  <13 years old 3 0 795 1
  13-19 years old 4 0 0 1 0 1
  20-44 years old 946 64 50,105 63
  >44 years old 527 36 27,836 35
  Total 1,480 100 79,531 100

 
ADAP Clients Served by Income, June 2002  
  VA
#
VA
%
US
#
US
%
  <100% FPL 898 61 38,175 48
  101-200% FPL 333 23 26,245 33
  201-300% FPL 83 6 8,748 11
  301-400% FPL 0 0 3,181 4
  >400% FPL 0 0 1,591 2
  Total 1,480 100 79,531 100

 
Insurance Coverage of ADAP Clients, June 2002  
  VA
#
VA
%
US
#
US
%
  Medicaid 55 4 0 10
  Medicare 104 7 0 6
  Private 55 4 0 13

 
National ADAP Budget, Total Federal and State Sources, FY 2002  
  VA
$
US
$
   16,747,186 878,610,754

 
National ADAP Budget by Source, FY 2002  
  VA
$
VA
%
US
$
US
%
  ADAP Earmark 12,099,043 72 619,830,000 71
  Title II Base 43,468 0 28,886,192 3
  State 2,612,200 16 160,385,979 18
  Title I 0 0 19,736,619 2
  Other Federal 177,700 1 30,941,439 4
  ADAP Supplemental Grants 1,814,775 11 19,170,000 2
  Total 16,747,186 100 878,610,754 100

 
Total ADAP Drug Expenditures, June 2002  
  VA
$
US
$
   1,310,346 70,705,142

 
ADAP Drug Expenditures by Drug Class, June 2002  
  VA
$
VA
%
US
$
US
%
  Nucleoside Reverse Transcriptase Inhibitors 697,918 53 31,486,146 49
  non-Nucleoside Reverse Transcriptase Inhibitors 192,505 15 7,940,575 12
  Protease Inhibitors 316,847 24 16,433,502 25
  Opportunistic Infections/Other 103,076 8 9,015,329 14
  Total 1,310,346 100 64,875,793 100

 
Total ADAP Prescriptions Filled, June 2002  
  VA
#
US
#
   4,852 257,279

 
ADAP Prescriptions Filled by Drug Class, June 2002  
  VA
#
VA
%
US
#
US
%
  Nucleoside Reverse Transcriptase Inhibitors 2,326 48 83,166 36
  non-Nucleoside Reverse Transcriptase Inhibitors 686 14 23,933 10
  Protease Inhibitors 826 17 33,813 15
  Opportunistic Infections/Other 1,014 21 87,746 38
  Total 4,852 100 228,771 100

 
Federal ADAP Funds Used for Insurance Purchasing/Maintenance, FY 2002  
  VA
$
US
$
   NA 18,486,544

 
ADAP Formularies, Number of Medications by Drug Class, 2002  
  VA
#
US
#
  Nucleoside Reverse Transcriptase Inhibitors 9 NA
  Protease Inhibitors Covered 6 NA
  Non-nucleosides Covered 3 NA
  OI Prophylaxis Covered 11 NA
  Other Medications Covered 22 NA
  Total 51 NA

 
ADAP Emergency Cost Containment Measures, February 2003  
  VA
 
US
 
  Has ADAP Emergency Cost Containment Measures in Place No 16 Yes